Similar articles

• [Conclusive evaluation of osteoporosis therapy with fluorides].

  Hesch RD, Rittinghaus EF. Hesch RD, et al. Internist (Berl). 1991 Dec;32(12):708-20. Internist (Berl). 1991. PMID: 1783513 Review. German. No abstract available.
• [Fluoride in osteoporosis: still an experimental and controversial treatment].

  Lips P. Lips P. Ned Tijdschr Geneeskd. 1998 Aug 22;142(34):1913-5. Ned Tijdschr Geneeskd. 1998. PMID: 9856177 Review. Dutch.
• Fluoride therapy for the vertebral crush fracture syndrome. A status report.

  Heaney RP, Baylink DJ, Johnston CC Jr, Melton LJ 3rd, Meunier PJ, Murray TM, Nagant de Deuxchaisnes C. Heaney RP, et al. Ann Intern Med. 1989 Oct 15;111(8):678-80. doi: 10.7326/0003-4819-111-8-678. Ann Intern Med. 1989. PMID: 2679286 Review. No abstract available.
• Fluoride salts for vertebral osteoporosis: the benefit-to-risk ratio depends on the cumulative dose reaching bone.

  Meunier PJ, Boivin G. Meunier PJ, et al. Osteoporos Int. 1993;3 Suppl 1:211-4. doi: 10.1007/BF01621910. Osteoporos Int. 1993. PMID: 8461564 No abstract available.
• [The pros and cons of sodium fluoride therapy in osteoporosis].

  Zippel C, Rempel H, Schmidt UJ. Zippel C, et al. Z Alternsforsch. 1975;30(2):173-9. Z Alternsforsch. 1975. PMID: 1226822 German. No abstract available.